535 related articles for article (PubMed ID: 33400964)
1. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles for drug delivery to the central nervous system.
Patel T; Zhou J; Piepmeier JM; Saltzman WM
Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
[TBL] [Abstract][Full Text] [Related]
4. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
[TBL] [Abstract][Full Text] [Related]
5. Strategies for transporting nanoparticles across the blood-brain barrier.
Zhang TT; Li W; Meng G; Wang P; Liao W
Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
7. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
8. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of biologics to the central nervous system.
Lochhead JJ; Thorne RG
Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
Ceña V; Játiva P
Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
[No Abstract] [Full Text] [Related]
12. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
13. Delivery of therapeutics to the central nervous system.
Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
[No Abstract] [Full Text] [Related]
14. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
Gao H; Pang Z; Jiang X
Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
[TBL] [Abstract][Full Text] [Related]
15. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles-based delivery system and its potentials in treating central nervous system disorders.
Liu T; Xie Q; Dong Z; Peng Q
Nanotechnology; 2022 Aug; 33(45):. PubMed ID: 35917704
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnologies: a strategy to overcome blood-brain barrier.
De Rosa G; Salzano G; Caraglia M; Abbruzzese A
Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
[TBL] [Abstract][Full Text] [Related]
19. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
